PSX vs URGN · P/E 17, rev $83.54B vs rev $123.4M
Phillips 66 (PSX) versus UroGen Pharma Ltd (URGN) — a side-by-side from cached financials, not a winner call.
Phillips 66 (PSX) is a oil & gas refining & marketing company listed on NYSE.
UroGen Pharma Ltd (URGN) is a biotechnology company listed on NASDAQ.
Latest reported PSX revenue for 2026-06-30 was $83.54B. Net income was $4.05B. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
Latest reported URGN revenue for 2026-06-30 was $123.4M. Net income was -$37.9M. URGN currently screens at market cap $1.61B.
PSX currently screens at market cap $67.02B and trailing P/E 16.5. URGN currently screens at market cap $1.61B.
Not investment advice. Open the PSX and URGN stock pages for the full models.
Not investment advice.